Bispecific Antibody Targeting VEGF/TGF-β Synergizes with Local Radiotherapy: Turning Tumors from Cold to Inflamed and Amplifying Abscopal Effects.

Adv Sci (Weinh) · 2025 · PMC12376579 · PMID 40470716

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In the tumor stromal remodeling panel (Figure 7i ), Y332D significantly decreased the scores of TGF‐β signaling, EMT, ECM, and VEGF pathway signatures compared to the vehicle, while RT showed a trend toward increasing these scores versus the vehicle.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.